Assenagon Asset Management S.A. Fate Therapeutics Inc Transaction History

Assenagon Asset Management S.A.

$39.3 Billion
Q2 2024

A detailed history of Assenagon Asset Management S.A. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 2,574,703 shares of FATE stock, worth $9.01 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,574,703

Previous 2,548,304 1.04%

Holding current value

$9.01 Million

Previous $18.7 Million 54.85%

% of portfolio

0.02%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$3.26 - $7.08 $86,060 - $186,904	26,399 Added 1.04%	2,574,703 $8.45 Million
Q1 2024 Apr 24, 2024	BUY	$3.54 - $8.35 $8.44 Million - $19.9 Million	2,385,207 Added 1462.45%	2,548,304 $18.7 Million
Q4 2023 Jan 17, 2024	SELL	$1.65 - $3.94 $359,106 - $857,501	-217,640 Reduced 57.16%	163,097 $609,000
Q3 2023 Nov 06, 2023	BUY	$2.02 - $5.04 $567,407 - $1.42 Million	280,895 Added 281.34%	380,737 $807,000
Q2 2023 Jul 25, 2023	BUY	$4.76 - $6.59 $475,247 - $657,958	99,842 New	99,842 $475,000
Q3 2022 Oct 27, 2022	SELL	$21.04 - $36.06 $441 - $757	-21 Reduced 0.14%	14,583 $327,000
Q2 2022 Jul 27, 2022	SELL	$17.78 - $42.39 $106 - $254	-6 Reduced 0.04%	14,604 $362,000
Q1 2022 Apr 25, 2022	SELL	$29.67 - $60.28 $148 - $301	-5 Reduced 0.03%	14,610 $566,000
Q4 2021 Feb 01, 2022	SELL	$47.84 - $64.34 $5.26 Million - $7.07 Million	-109,893 Reduced 88.26%	14,615 $855,000
Q3 2021 Oct 19, 2021	SELL	$59.27 - $95.73 $17.4 Million - $28 Million	-292,850 Reduced 70.17%	124,508 $7.38 Million
Q2 2021 Jul 15, 2021	BUY	$67.25 - $92.52 $28.1 Million - $38.6 Million	417,358 New	417,358 $36.2 Million
Q1 2021 Apr 26, 2021	SELL	$72.16 - $117.4 $1.83 Million - $2.97 Million	-25,323 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$38.09 - $100.95 $2.2 Million - $5.83 Million	-57,776 Reduced 69.53%	25,323 $2.3 Million
Q3 2020 Oct 07, 2020	BUY	$30.41 - $40.5 $1.3 Million - $1.73 Million	42,721 Added 105.8%	83,099 $3.32 Million
Q2 2020 Jul 21, 2020	BUY	$20.21 - $35.23 $816,039 - $1.42 Million	40,378 New	40,378 $1.39 Million

Others Institutions Holding FATE

# of Institutions

190

Shares Held

123M

Call Options Held

15K

Put Options Held

14K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $340M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Fate Therapeutics Inc Transaction History